Introduction
Relapsing polychondritis is a rare inflammatory disorder in which the immune system repeatedly attacks cartilage and related connective tissues. Cartilage is the flexible structural tissue that gives shape and support to the ears, nose, joints, and parts of the respiratory tract. In this condition, the body’s own immune and inflammatory pathways become directed against components of cartilage, especially molecules in the cartilage matrix such as type II collagen and associated proteins. The result is episodic, recurrent inflammation that can damage cartilage, weaken supporting structures, and alter the function of tissues that depend on cartilage for stability.
The condition is defined less by a single organ defect than by a pattern of immune-mediated injury. Its core biological feature is inflammation of cartilage, or chondritis, that tends to recur over time. Because cartilage is present in several regions of the body, the disease can affect multiple systems at once, particularly the ears, nose, joints, and airways. The name reflects this repeated pattern: relapsing refers to flares that come and go, and polychondritis refers to inflammation in more than one cartilaginous site.
The Body Structures or Systems Involved
Relapsing polychondritis primarily affects cartilage, a specialized connective tissue made of chondrocytes embedded in an extracellular matrix rich in collagen, proteoglycans, and water. Unlike bone, cartilage has no direct blood supply. It depends on diffusion from surrounding tissues for nutrients and oxygen, which limits its ability to repair itself after injury. This structural feature helps explain why repeated inflammation can lead to lasting deformity.
Several parts of the body are especially vulnerable. The external ear contains elastic cartilage that maintains its curved shape. The nasal bridge contains cartilage that supports the midline of the face. The larynx and trachea contain cartilage rings and plates that help keep the airway open during breathing. The ribs connect to the sternum through costal cartilage, and joints contain articular cartilage that helps surfaces glide smoothly. Relapsing polychondritis can involve any of these areas because they all rely on cartilage for mechanical support.
The immune system is also central to the disease. T cells, B cells, macrophages, and inflammatory signaling molecules such as cytokines participate in the tissue injury. The disorder is therefore not simply a local cartilage problem; it reflects abnormal immune recognition and sustained inflammatory activation. In more severe cases, adjacent structures such as the eyes, blood vessels, heart valves, and inner ear may also be involved, suggesting broader inflammation of connective tissue and possibly small or medium vessels in some patients.
How the Condition Develops
Relapsing polychondritis is thought to begin when immune tolerance to cartilage components breaks down. In a healthy person, the immune system distinguishes self from non-self and avoids attacking normal tissues. In this disorder, evidence suggests that the immune system mistakenly recognizes cartilage matrix molecules as targets. Type II collagen is one of the best studied candidate antigens, although other cartilage-associated proteins may also be involved. Once this self-reactive response begins, immune cells release inflammatory mediators into the cartilage and surrounding perichondrium, the thin layer of tissue that nourishes cartilage.
The inflammatory process recruits additional immune cells into the affected tissue. T lymphocytes can drive the response by producing cytokines that activate macrophages and other effector cells. These cells in turn release enzymes, oxidants, and additional cytokines that degrade the cartilage matrix and injure chondrocytes. Because cartilage has limited regenerative capacity, repeated cycles of injury and repair do not restore normal structure completely. Instead, the tissue may become weakened, irregular, or permanently distorted.
The mechanism is often episodic rather than continuously progressive. During a flare, immune activity rises in one or more cartilaginous sites and inflammation becomes clinically apparent. Between flares, the process may quiet down, but the underlying immune dysregulation can remain. Over time, repeated inflammatory episodes can cause cumulative structural damage. This waxing and waning behavior is a hallmark of the disorder and helps distinguish it from conditions that produce constant, uniform tissue loss.
In the airway, the biology of the disease has especially important consequences. Tracheal and laryngeal cartilage provide a rigid scaffold that prevents collapse during breathing. When inflammatory injury weakens this support, the airway can become narrowed or unstable. This is not simply swelling; it is a change in the mechanical integrity of the cartilage framework itself. Similar principles apply in the ear and nose, where cartilage damage can lead to altered shape because the normal structural matrix has been compromised.
Structural or Functional Changes Caused by the Condition
The most direct structural change is cartilage inflammation and destruction. During active inflammation, the cartilage matrix becomes infiltrated by immune cells and inflammatory fluid. Chondrocytes may be damaged or lost, and the surrounding matrix may lose proteoglycans and collagen integrity. As the tissue weakens, it can no longer maintain its normal form and stiffness. Over time this may lead to softening, thinning, or collapse of the affected cartilage.
When the external ear is involved, the inflamed cartilage can lose its normal resilience and contour because the earlobe itself is spared while the cartilaginous part of the pinna is affected. In the nose, destruction of nasal cartilage can reduce support for the bridge of the nose. In the respiratory tract, weakening of tracheal and bronchial cartilage can impair airway patency. The functional result is a loss of mechanical stability in structures that depend on cartilage as a supportive framework.
Inflammation can also extend beyond cartilage. The synovial tissues of joints may become inflamed, leading to impaired motion and pain through inflammatory changes in the joint lining. Ocular involvement reflects inflammatory injury in tissues rich in connective tissue and immune surveillance, such as the sclera, conjunctiva, or corneal adjacent structures. In some patients, inner ear structures may be affected, potentially disturbing balance and hearing through inflammation of nearby cartilaginous and supporting tissues.
From a physiological standpoint, the disease alters local tissue architecture, mechanical support, and inflammatory signaling. Swelling alone is not the main issue. The more important effect is the breakdown of an extracellular matrix that normally resists deformation. Once that matrix is damaged, even brief inflammatory episodes can have lasting consequences because cartilage does not regenerate efficiently in the same way as highly vascular tissues.
Factors That Influence the Development of the Condition
The exact cause of relapsing polychondritis is not fully established, but several factors appear to influence its development. Genetic susceptibility is one of the most likely contributors. Certain immune-related genetic backgrounds, including some HLA types, may make an individual more prone to losing tolerance to cartilage antigens. These genetic factors do not cause the disease on their own, but they can shape how the immune system recognizes self-tissues.
Environmental triggers may help initiate or amplify the immune response in susceptible people. Infections are often considered possible triggers because they can activate innate immunity and create a state of immune stimulation that increases the chance of cross-reactivity with self-antigens. A pathogen might share structural similarity with a cartilage protein, or infection may simply heighten inflammatory signaling enough to expose a latent autoimmune tendency. The evidence is not uniform for a single infectious cause, but immune activation is a plausible bridge between susceptibility and onset.
Other autoimmune or inflammatory conditions can coexist with relapsing polychondritis, suggesting that broader immune dysregulation may be part of the background. This overlap supports the idea that the disease arises from a combination of immune tolerance failure, inflammatory amplification, and possibly shared genetic pathways rather than from one isolated defect. Hormonal influences may also affect immune reactivity, but they are not as clearly defined as the immune and genetic contributors.
Lifestyle factors are not considered primary causes. Unlike conditions in which diet or habits directly drive pathology, relapsing polychondritis is mainly an immune-mediated disease. External factors may influence immune activity indirectly, but the core mechanism remains inappropriate inflammation directed at cartilage components.
Variations or Forms of the Condition
Relapsing polychondritis can vary substantially in presentation because the underlying immune attack may be localized or widespread. Some individuals have inflammation confined to a small number of cartilaginous sites, while others develop multi-organ disease involving the ears, nose, joints, airway, eyes, and cardiovascular structures. This difference reflects how broadly the immune response is distributed and which tissues are exposed to the inflammatory process.
Another variation concerns the balance between episodic flares and more persistent damage. In some cases, inflammation is intermittent and separated by periods of relative quiescence. In others, repeated episodes occur close together, leading to faster cumulative injury. The severity of structural damage depends not only on how often flares occur, but also on which tissues are involved. Airway cartilage damage has greater physiological consequences than isolated external ear involvement because it affects ventilation and airway stability.
Some forms are predominantly chondral, meaning they mainly involve cartilage, while others show broader connective tissue or vascular involvement. When the disease extends beyond cartilage, it may affect tissues that share similar extracellular matrix components or nearby immune environments. This broader pattern may indicate a stronger systemic immune response rather than a process limited to a single cartilage site.
The disease can also differ in the degree to which inflammation causes permanent change. Early in the course, tissue injury may be largely reversible once inflammation subsides. With repeated episodes, however, the structural framework becomes progressively compromised. The same immune process therefore can produce very different outcomes depending on duration, distribution, and intensity.
How the Condition Affects the Body Over Time
Over time, relapsing polychondritis can move from intermittent inflammation to accumulated structural loss. Each flare has the potential to injure cartilage a little more, and because cartilage repair is limited, the tissue may gradually lose elasticity and strength. This progressive weakening can alter the shape of affected structures and impair their function even when active inflammation is not present.
In the respiratory system, repeated injury can be especially consequential. The trachea and bronchi depend on cartilaginous support to remain open. Chronic weakening may produce dynamic airway collapse, narrowing, or structural instability. These changes reflect mechanical failure of the airway wall rather than a transient inflammatory swelling alone. Once the cartilage scaffold has been compromised, breathing mechanics can be altered in a lasting way.
In the ears and nose, the long-term effect is a change in form caused by loss of supportive cartilage. In joints, ongoing inflammation can interfere with smooth movement by disturbing the normal properties of articular tissues. If the inflammatory process reaches the eyes, ears, heart, or blood vessels, the long-term burden becomes broader and more complex because multiple organ systems may be affected simultaneously.
The body may respond by maintaining a low-grade inflammatory state between flares, or by developing scarring and fibrotic remodeling in damaged tissues. These changes do not restore the original cartilage architecture; instead, they replace it with less specialized structural material. The result is that the disease can become partly self-perpetuating: damaged tissue alters local function, which may increase mechanical stress or vulnerability in the same area during later episodes.
Conclusion
Relapsing polychondritis is a rare immune-mediated disorder characterized by recurrent inflammation of cartilage and other connective tissues. Its defining feature is a loss of immune tolerance to cartilage components, leading to repeated inflammatory injury in structures such as the ears, nose, joints, and airways. The disease develops through interactions among immune cells, inflammatory mediators, and the cartilage matrix, which together produce tissue damage that cartilage cannot easily repair.
Understanding the condition requires seeing both its biological target and its mechanical consequences. Cartilage is not just passive support tissue; it is a specialized structure that preserves the shape and function of multiple organs. When inflammation repeatedly disrupts that structure, the body can lose support, stability, and normal organ mechanics. The pattern of relapsing inflammation and cumulative cartilage injury is what defines relapsing polychondritis and explains how it changes the body over time.